Save the dates for the 3rd Pharma Due Diligence Conference 2023, happening on September 7-8 in Shanghai. 

This conference is dedicated to exploring due diligence topics within the biopharmaceutical industry and serves as a hub for professionals from biopharmaceutical companies, investment institutions, law firms, due diligence service providers, and related sectors to exchange insights.

Dr. Dewan Zeng, Innoforce CEO, will participate in the panel discussion at 11:15 am on Sept. 7, where she will join industry experts to share her insights on “Optimal International Expansion Strategies and Vital Considerations,” providing valuable guidance and expertise.